Lecznictwo doświadczalnej toksoplazmozy

• Autorzy: Galuszka J. , Szaflarski J.

Warianty tytułu

EN

Therapy of experimental toxoplasmosis

RU

Terapija ehksperimental'nogo toksoplazmoza

• Języki publikacji: PL
• Wydawca: -
• Czasopismo: Wiadomości Parazytologiczne
• Rocznik: 1963
• Tom: 09
• Numer: 2
• Opis fizyczny: s.101-108,bibliogr.

Twórcy

autor

Galuszka J.

• Wojewódzki Zakład Higieny Weterynaryjnej, Katowice

autor

Szaflarski J.

• Wojewódzki Zakład Higieny Weterynaryjnej, Katowice

Bibliografia

• 1. Adams F. H., Cooney M., Adams J. M., Kabler P.: Experimental toxoplasmosis. - Proc. Soc. Exp. Biol. Med. 70: 258-260, 1949.
• 2. Beverley J. K. A., Beattie C. P., Fry B. A.: Experimental toxoplasmosis of the uveal tract. - Brit. J. Ophth., 38: 489-496, 1954.
• 3. Beverly J. K. A., Fry B. A.: The treatment of experimental toxoplasmosis in rabbits. - Brit. J. Pharmacol. a. Chemotherap. 12: 185, 1957.
• 4. Beverley J. K. A., Fry B. A.: Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice. - Brit. J. Pharmacol. a. Chemotherap. 12: 189, 1957.
• 5. Bimmer E., Mohr W.: Therapie Versuche bei experimenteller Mäuse. - Toxoplasmose. - Zeitsclir. Tropenmed. u. Parasitol. 9: 225-234, 1958.
• 6. Biocca E., Pasqualin R.: A acao terapeutica de alguns compostos sulfanilamidicos na infeccao experimental por Toxoplasma. - Arq. biol. S. Paulo 26: 107-109, 1942.
• 7. Biocca E.: Quimioterapia sulfonica da toxoplasmose. - Arq. biol. S. Paulo 27: 7-10, 1943.
• 8. Biocca E.: Atividade quimioterapica da 4-nitro-4'-formilaminodifenilsulfona (composto 117 M). - Arq. biol. S. Paulo 27: 63-64, 1943.
• 9. Biocca E.: Observacoes ulteriores na quimioterapia da toxoplasmose. - Arq. biol. S. Paulo 27: 89-91, 1943.
• 10. Biocca E.: Resistencia a reinfeccoes de toxoplasma em animals tratados da toxoplasmose experimental com differentes substancias quimioterapicas. - Arq. biol. S. Paulo 29: 82-84, 1945.
• 11. Biocca E., Nobrega P.: Sobre a quimioterapia da toxoplasmose. - Arq. biol. S. Paulo 30: 63-66, 1946.
• 12. Bogacz J.: La magnamycine et l'ilotycine. Leur action vis-a-vis des toxoplasmes. - Compt. Rend. Soc. Biol. 148: 276-278, 1954.
• 13. Bogacz J.: Action comparee sur les toxoplasmes de diverses substances synthetiques et de quelques antibiotiques dont la spiramycine. - Bull. Soc. Path. Exot. 47: 903-913, 1954.
• 14. Bonaduce A.: Ricerche sull'azione della spiramicina nella toxoplasmosi sperimentale del topino bianco. - Bol. Soc. Ital. biol. sper. 36: 57-59, 1960.
• 15. Christen R., Thiermann E.: Quimioterapia experimental da la toxoplasmosis. II. Efecto de la acromicina sobre toxoplasmosis experimental del ratón. - Biol. inform. parasitol. Chilenas 8: 49-51, 1953.
• 16. Chruściel T., Gałuszka J., Samochowiec L., Szaflarski J.: A Trial of the treatment of experimental toxoplasmosis in mice. I. The influence of pyrimethamine, triacetyloleandomycin, proguanil, TCI, TBr and TJ on the course of acute toxoplasmosis in mice. - Acta Parasitol. Polon. 1962 (in press).
• 17. Chruściel T., Gałuszka J., Samochowiec L., Szaflarski J.; A Trial of the treatment of experimental toxoplasmosis in mice. II. The influence of chloroproguanil, triparanol, novobiocin, DED, J1, ED5 and pyrimethamine on the course of subacute toxoplasmosis in mice. - Acta Parasitol. Polon., 1962 (in press).
• 18. Chruściel T., Gałuszka J., Samochowiec L., Szaflarski J.: A Trial of the treatment of experimental toxoplasmosis in mice. III. The influence of metronidazole, nitroguanil and the effects of combined treatment with rovamycin and 2-sulfanilamido-5-methoxypyrimidine on the course of subacute toxoplasmosis in mice. - Acta Parasitol. Polon. 1962 (in press).
• 19. Crema A., Ambreck A.: Contributo all o studio dell'azione esercitata dell'aureomicina e terramicina in vitro e in vivo, della tirotricina in vitro e della proteino - terapia aspecifica sulla toxoplasmosi sperimentale. - Boll. Soc. Ital. biol. sper. 28: 650-654, 1952.
• 20. Crema A., Ambreck A.: Alcuni singolari aspetti della toxoplasmosi sperimentale in topi trattati con aureomicina. - Boll. Soc. Ital. biol. sper. 2.8: 1508-1510, 1952.
• 21. Cross J. B., Joseph H.: Chloromycetin and experimental toxoplasmosis. - Texas Repts. Biol. a. Med. 7: 406, 1949.
• 22. Cross J. B.: Diasone and promin as therapeutic agents in experimental toxoplasmosis. - Proc. Soc. Exp. Biol. N. Y. 76: 548-551, 1951.
• 23. Cross J. B.: Diasone, avlosulfon and sulphetrone as therapeutic agents in experimental toxoplasmosis. - Am. J. Trop. Med. Hyg. l: 593-597, 1952.
• 24. Doleżał M., Przybyłkiewicz Z., Starzyk J.: Wpływ i działanie chlorpromazyny na przebieg doświadczalnej toksoplazmozy u białych myszy. - Acta Parasitol. Polon. 4: 555-560, 1956.
• 25. Eichenwald H.: Experimental toxoplasmosis. II. Effect of sulfadiazine and antiserum on congenital toxoplasmosis in mice. - Proc. Soc. Exp. Biol. 71: 45-49, 1949.
• 26. Eyles D. E., Coleman N.: Tests of 2,4-diaminopyrimidines on toxoplasmosis. - Public Health Rept. 67: 249-252, 1952.
• 27. Eyles D. E., Coleman N.: The relative activity of the common sulfonamides against experimental toxoplasmosis in the mouse. - Am. J. Trop Med. Hyg., 2: 54-63, 1953.
• 28. Eyles D. E., Coleman N.: Antibiotics in the treatment of toxoplasmosis. - Am. J. Trop. Med. Hyg., 2: 64-69, 1953.
• 29. Eyles D. E., Coleman N.: Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse. - Antibiotics a. Chemotherap. 3: 483-490, 1953.
• 30. Eyles D. E., Coleman N.: Le traitement de la toxoplasmose experimentale aigue de la souris par la terramycine. - Bull. Soc. Path. Exot. 6: 952-953, 1953.
• 31. Eyles D. E., Coleman N.: The antitoxoplasmic activity of puromycin. - Antibiotics a. Chemotherap. 4: 649-652, 1954.
• 32. Eyles D. E., Coleman N.: Notes on the treatment of acute experimental toxoplasmosis of the mouse with chlortetracycline and tetracycline. - Antibiotics a. Chemotherap. 4: 988-991, 1954.
• 33. Eyles D. E., Coleman N.: The effect of sulfadimetinc, sulfisoxazole and sulfapyrazine against mouse toxoplasmosis. - Antibiotics a. Chemotherap.. 5: 525-528, 1955.
• 34. Eyles D. E., Coleman N.: An evaluation of the curativc effects of pyrimethamine and sulfadiazine, alone and in combination on experimental mouse toxoplasmosis. - Antibiotics a. Chemotherap. 5: 529-539, 1955.
• 35. Eyles D. E., Jones F. E.: The chemotherapeutic effect of pyrimethamine and sulfadiazine on toxoplasmosis of the norway rat. - Antibiotics a. Chemotherap. 5: 731-734, 1955.
• 36. Frenkel J. K.: Therapeutic efficacy of sulfonamides and aureomycin in acute murine toxoplasmosis as measured by the development of chronicity and by cure with and without presence of antibody. - Federation Proc. 13: 429, 1934.
• 37. Frenkel J. K., Nelson T. L., Jacobs L.: Status of aureomycin treatment of primates with antibodies to Toxoplasma. - Zbl. Bakt. I. Abt. Orig. 161: 390-395, 1954.
• 38. Gałuszka J., Szaflarski J.: Diacycline treatment of acute experimental toxoplasmosis in mice. - Arch. Immunol. Therap. Exp. (in press).
• 39. Garin J. P.: Toxoplasmose experimentale aigue de la souris, echec du traitement par l'histoplasmine. - Bull. Soc. Path. Exot. 46: 323-324, 19.53.
• 40. Garin J. P.: Toxoplasmose experimentale aigue de la souris, echec du traitement par la terramycine. - Bull. Soc. Path. Exot. 46: 325-327, 1953.
• 41. Garin J. P., Eyles D. E.: Le traitement de la toxoplasmose experimentale de la souris par la spiramycine. - La Presse Medicale 66: 957-958, 1958.
• 42. Gingrich W. D., Darrow E. M.: The effect of endochin on experimental toxoplasmosis. - Am. J. Trop. Med. 31: 12-17, 1951.
• 43. Giroud P., Gaillard J. A.: Action comparee de la terramycine et de l'aureomycine sur les toxoplasmoses. - Compt. Rend. Acad. Sci. 232: 1457-1459, 1951.
• 44. Grassi C.: Tiosemicarbazoni, aureomicina e terramicina nella toxoplasmosi sperimentale. - Atti Soc. Lombarda di Sci. Med. e Biol. 7: 23-27, 1951.
• 45. Grassi C., Kass E.: Failure of terramycin treatment in acute experimental toxoplasmosis. - Acta Pathol. Microbiol. Scand. 30: 304-305, 1952.
• 46. Grönroos P.: Antibiotics and experimental toxoplasmosis. Polymyxin B-sulfate, bacitracin, terramycin, aureomycin and sulfa in experimental toxoplasmosis. - Ann. Med. Exp. Biol. Fenniae 31: 374-377, 1953.
• 47. Grönroos P.: Antibiotics and experimental toxoplasmosis. II. Erythromycin, magnamycin, neomycin and tabezon in experimental toxoplasmosis. - Ann. Med. Exp. Biul. Fenniae 32: 257-259, 1954.
• 48. Kass E., Steen E.: Aureomycin treatment of acute experimental toxoplasmosis in rabbits. - Acta Path. Microbiol. Scand. 28: 165-168, 1951.
• 49. Knap p W.: Über chemotherapeutische Versuche am Erreger der Toxoplasmose. - Med. Welt. 20: 554-556, 1951.
• 50. Lapierre J., Lariviere M., Gilles R.: Action de differents antibiotiques vis-a-vis de la toxoplasmose experimentale de la souris (erythromycine, magnamycine, sulfadimerazine). - Ann. Parasitol. hum. comp. 30: 153-155, 1955.
• 51. Lutochin S. I.: K woprosu leczenija eksperimentalnogo toksoplazmoza. - Wietierinaria 3: 60, 1962.
• 52. Mc Cowen M. C., Callender M. E., Lawlis J. F Jr., Brandt M. C.: The effects of erythromycin (Ilotycin, Lilly) against certain parasitie organisms. - Am. J. Trop. Med. Hyd. 2: 212-218, 1953.
• 53. Nobrega P., Giovannoni M.: Sobre a acao da terramicina da toxoplasmose Experimental. - Arq. biol. S. Paulo 21: 5-12, 1952.
• 54. Palencia L., Gonzalez R., Varela G.: Terapeutica de la toxoplasmosis experimental del raton blanco con tetracidina, synnemation B, methymycin, D-510 sirex, bemarsal, camoquinal y azacrin. - Rev. inst. Salubr. y enfermedad trop. Mex. 14: 113-116, 1954.
• 55. Palencia L., Gonzalez R., Varela G.: Comparación de la accion terapeutica del daraprim y de la tetraciclina en la toxoplasmosis aguda experimental del ratón blanco. -Prensa med. Mez. 19: 279-280, 1954.
• 56. Puech J.: Terramycine et toxoplasmose experimentale du lapin. Ann. Parasitol. Hum. Comp. 2: 419-420, 1952.
• 57. Sabin A. B., Warren J.: Therapeutic effect of the sulfonamides on infection by an intracellular protozoan (Toxoplasma) - Abstr..J. Bacteriol. 41: 80, 141.
• 58. Sabin A. B., Warren J.: Therapeutic effectiveness of certain sulfonamides on infection by an intracellular protozoan (Toxoplasma). - Proc. Soc. Exp. Biol. Med. 51: 19-23, 1942.
• 59. Starzyk J., Dutkiewicz J.: Wpływ DDT na Toxoplasma gondii. - Wiad. Parazytol. 5: 61, 1956.
• 60. Starzyk J., Haslinger R., Doleżał M.: Wpływ tanacetyny na Toxoplasma gondii. - Wiad. Parazytol. 5: 51-52, 1956.
• 61. Steen E.: Acute experimental toxoplasmosis treated with aureomycin. - Acta Pathol. Microbiol. Scand. 27: 844-850, 1950.
• 62. Summers W. A.: Antagonism of sulfonamide inhibition by para-aminobenzoic acid and folic acid in Toxoplasma infected mice. - Proc. Soc. Exp. Biol. Med. 66: 509-511, 1947.
• 63. Summers W. A.: The effects of oral administration of aureomycin, sulfathiazole, sulfamerazine and 4,4'-diaminodiphenylsulfone on toxoplasmosis in mice. - Am. J. Trop. Med. 29: 889-893, 1949.
• 64. Summers W. A.: The chemotherapeutic efficacy of 2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine (Daraprim) in experimental toxoplasmosis. - Am. J. Trop. Med. Hyg. 2: 1037-1044, 1953.
• 65. Summers W. A., Eyles D. E.: Drug activity against experimental toxoplasmosis. - Summary and tables of biological tests (Nat. Acad. Sci., Nat. Res. Council) 9: 364-448, 1957.
• 66. Thalhammer O., Schnabl E., Moritsch H.: Behandlungsversuch experimenteller Toxoplasmose mit Sulfonamid und Aureomycin. - Wien. Z. Inn. Med. 32: 262-266, 1951.
• 67. Thiel P. H. van: De therapie van experimentele toxoplasmosis met enkele sulfonamides, arseenverbindingen en antimalariamiddelen. - Ned. Tijdschr. Geneesk. 93: 3818-3820, 1949.
• 68. Trevino, A., Varela G., Palencia L.: Terapeutica de la toxoplasmosis experimental del ratón blanco con hidroxicloroquina (Win 1258-2), 5-p-clorofenil-2,4-diamino-6-etilpirimidina (Pirimetamina o Daraprim) y Fumagilina (Fumidil). - Rev. inst. Salubr. y enfermedad trop. Mex. 13: 399-341, 1953.
• 69. Warren J., Sabin A. B.: Effect of certain antiprotozoal drugs on Toxoplasma in vitro and in vivo. - Proc. Soc. Exp. Biol. Med. 51: 15-18, 1942.
• 70. Weinman D., Berne R.: Therapeutic cure of acute experimental toxoplasmosis in animals. - J. Am. Med. Ass. 124: 6-8, 1944.
• 71. Westphal A.: Das Vorkommen von Toxoplasmose in Deutschland und ihre Behandlungsmöglichkeit mit Aureomycin. - Z. Tropenmed. u. Parasitol. 1: 526-532, 1950.
• 72. Wettingfeld R. F., Rowe J., Eyles D. E.: Treatment of toxoplasmosis with pyrimethamine and triple sulfonamide. - Ann. Int. Med. 44: 557-564, 1956.
• 73. Wolf A., Cowen D.: Granulomatous encephalmyelitis due to an encephalitozoon (encephalitozoic encephalomyelitis). A new protozoan disease of man. - Bull. Neurol. Inst. N. Y. 6: 306-371, 1937.
• 74. Wolf A., Cowen D., Palge B. H.: Toxoplasmosic encephalomyelitis. III. A new case of granulomatous encephalomyelitis due to a protozoan. - Am. J. Pathol. 15: 657-694, 1939.
• 75. Wolfschlag H. J.: Tierexperimentelle Untersuchungen zur Therapie der Toxoplasmose. - Z. Kinderheilk. 69: 564-577, 1951.